Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: Treatment outcome and prognostic factors in PCNSL

Fig. 2

OS in 43 PCNSL patients with a germinal center B cell (GCB) and a non-GCB DLBCL (a), OS and RFS in 43 PCNSL patients with CD10+ and CD10- (b) OS and RFS in 43 PCNSL patients with BCL2+ and BCL2- (c), OS and RFS in 43 PCNSL patients with BCL2+ in GCB and BCL2+ in non GCB (d), OS in 43 PCNSL patients treated with chemotherapy, WBRT and chemotherapy combined with WBRT (e), RFS in 43 PCNSL patients treated with chemotherapy, WBRT and chemotherapy combined with WBRT (f)

Back to article page